Document is current
Any future updates will be listed below
-
Authors
Garg, Manik https://orcid.org/0000-0003-0453-2058
Karpinski, Marcin
Matelska, Dorota
Middleton, Lawrence https://orcid.org/0009-0002-2789-7244
Burren, Oliver S.
Hu, Fengyuan
Wheeler, Eleanor https://orcid.org/0000-0002-8616-6444
Smith, Katherine R. https://orcid.org/0000-0002-0329-5938
Fabre, Margarete A.
Mitchell, Jonathan
O’Neill, Amanda
Ashley, Euan A. https://orcid.org/0000-0001-9418-9577
Harper, Andrew R. https://orcid.org/0000-0001-5327-0328
Wang, Quanli
Dhindsa, Ryan S. https://orcid.org/0000-0002-8965-0813
Petrovski, Slavé https://orcid.org/0000-0002-1527-961X
Vitsios, Dimitrios https://orcid.org/0000-0002-8939-5445
- License Information
-
More Information
Article History
Received: 1 May 2024
Accepted: 7 August 2024
First Online: 11 September 2024
Competing interests
: M.G., M.K., D.M., L.M., O.S.B., F.H., E.W., K.R.S., M.A.F., J.M., A.O’N., E.A.A., A.R.H., Q.W., R.S.D., S.P. and D.V. are current employees and/or stockholders of AstraZeneca. E.A.A. is a founder of Personalis, Inc., DeepCell, Inc. and Svexa Inc.; a founding advisor of Nuevocor; a nonexecutive director at AstraZeneca; and an advisor to SequenceBio, Novartis, Medical Excellence Capital, Foresite Capital and Third Rock Ventures.
